GENPACT LIMITED
GENPACT LIMITED (G) has a dated report snapshot, but its current priced-in claim is temporarily suppressed because the live engine record is unavailable or has changed.
- At $28.25 Genpact trades below nearly every valuation method (blended landing near $48), with a 23% trailing ROE against a roughly 9% cost of equity and a high-single-digit forward P/E, the classic value-method mismatch. - The inversion implies an operating margin near 3.6% versus the 14.8% the company runs today, so the price is pricing significant margin erosion, the central debate is whether that happens. - The swing factor is AI: it powers the fast-growing Advanced Technology Solutions mix
Is G overvalued? See what's priced in →
496 institutional managers reported holding G in 13F filings for the quarter ended 2026-03-31. 71 opened new positions that quarter. Held by FMR (Fidelity), Vanguard Group, BlackRock, among others. On the short side, 17.8M shares were sold short as of the 2026-06-15 count, about 10% of shares outstanding (6.7 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
G has cut its share count 9.1% over the past five years, spending $365.15M on repurchases. It pays a dividend, and has for 9 years running, raised 8 years straight; the current rate is $0.68 a share annually. Cash returned over the past three years: $307.71M in dividends.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at G over the trailing three years: 2025: 1 buy totaling $88k. 22 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
G's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-10 | +4.9% | -4.1% |
| 2023-11-10 | -8.8% | +7.7% |
| 2024-03-01 | +4.9% | -7.7% |
| 2024-05-11 | +2.5% | -2.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
G's latest 8-K filings: 2026-05-07 (items 2.02, 9.01); 2026-04-29 (items 5.07); 2026-02-05 (items 2.02, 9.01); 2025-11-18 (items 1.01, 2.03, 9.01); 2025-11-06 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.